What Alexion Pharmaceuticals, Inc. pays on H-1B filings
Alexion Pharmaceuticals, Inc. filed 78 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.
FY2026 so far · 35 LCAsFY2025 · 43 LCAs
Stated wages by title
| Title | LCAs | Year | Typical range | Median |
|---|---|---|---|---|
| Associate Scientist | 12 | FY2026 so far | $94,211 to $100,920 | $99,689 |
| Associate Director | 5 | FY2026 so far | $161,803 to $201,058 | $178,000 |
| Scientist Injectable Drug Product Development | 4 | FY2026 so far | $128,340 to $142,766 | $135,000 |
| Associate Director | 3 | FY2026 so far | $169,770 to $211,378 | $190,574 |
Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.
Filings by fiscal year
| Fiscal year | Certified LCAs |
|---|---|
| FY2026 (October to June) | 35 |
| FY2025 | 43 |
By prevailing-wage level
| Level | LCAs | Median stated wage |
|---|---|---|
| Level I (entry) | 17 | $101,207 |
| Level II (qualified) | 26 | $139,653 |
| Level III (experienced) | 14 | $156,408 |
| Level IV (fully competent) | 19 | $161,803 |
| No level stated | 2 | $144,975 |
DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.
Top worksites
| Worksite | LCAs | Median stated wage |
|---|---|---|
| New Haven, CT | 33 | $125,318 |
| Boston, MA | 29 | $161,803 |
| Cambridge, MA | 5 | $145,000 |
Looking at Alexion Pharmaceuticals, Inc.?
Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.